Nur zu Informationszwecken. Lassen Sie sich immer von medizinischem Fachpersonal beraten.
MPMediPriceHubArzneimittelpreise im Überblick
PRODUCT INFORMATION

Sotyktu 6mg Filmtabletten,1 x 28ST(deucravacitinib)

deucravacitinib

Sotyktu 6mg Filmtabletten,1 x 28ST(deucravacitinib)
Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
BrandSotyktu
ManufacturerBristol-Myers Squibb GmbH & Co.KGaA
Prescription requiredYes

Description

Sotyktu 6mg Filmtabletten,1 x 28ST(deucravacitinib) is a medicine catalog record in the MediPriceHub database. Active ingredient: deucravacitinib. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Bristol-Myers Squibb GmbH & Co.KGaA. Therapeutic category: Medicine Library > Dermatology Medicines > Drugs for psoriasis. Pack information: 6, 1 x 28. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.

Benefits

SOTYKTU is a tyrosine kinase 2 (TYK2) inhibitor indicated for: Limitations of Use : Not recommended for use in combination with other potent immunosuppressants. • the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. • the treatment of active psoriatic arthritis in adults.

How to Use

Use deucravacitinib under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.

Specification

Active ingredient: deucravacitinib. Pack size: 6, 1 x 28. Pack unit: box. Manufacturer: Bristol-Myers Squibb GmbH & Co.KGaA. Origin country: Germany. Source category: Medicine Library > Dermatology Medicines > Drugs for psoriasis. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.

Side Effects

Possible adverse effects vary by active ingredient, dose, route, treatment duration, and patient condition. Common issues may include gastrointestinal symptoms, headache, dizziness, fatigue, rash, allergic reactions, or abnormal laboratory tests. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.

Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.